关注
CALOGERO CRAPANZANO
CALOGERO CRAPANZANO
Psychiatrist, Department of Mental Health, Provincial Health Company of Agrigento, Italy
在 aspag.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lithium and valproate in bipolar disorder: from international evidence-based guidelines to clinical predictors
C Crapanzano, I Casolaro, C Amendola, S Damiani
Clinical Psychopharmacology and Neuroscience 20 (3), 403, 2022
132022
Quetiapine in the anxiety dimension of mood disorders: a systematic review of the literature to support clinical practice
C Crapanzano, S Damiani, C Guiot
Journal of Clinical Psychopharmacology 41 (4), 436-449, 2021
102021
Quetiapine treatment for post-traumatic stress disorder: a systematic review of the literature
C Crapanzano, S Damiani, I Casolaro, C Amendola
Clinical Psychopharmacology and Neuroscience 21 (1), 49, 2023
72023
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder
M Ballerio, P Politi, C Crapanzano, E Emanuele, A Cuomo, A Goracci, ...
Neuroendocrinology Letters 39 (3), 205-208, 2018
72018
Vortioxetine-induced nausea and its treatment: a case report
C Crapanzano, A Politano, C Amendola, D Koukouna, I Casolaro
Archives of Clinical Psychiatry (São Paulo) 47 (5), 160-161, 2020
52020
Olanzapine for the treatment of somatic symptom disorder: biobehavioral processes and clinical implications
C Crapanzano, C Amendola, A Politano, PF Laurenzi, I Casolaro
Psychosomatic Medicine 84 (3), 393-395, 2022
42022
Clinical perspective on antipsychotic receptor binding affinities
C Crapanzano, PF Laurenzi, C Amendola, I Casolaro
Brazilian Journal of Psychiatry 43 (6), 680-681, 2021
42021
Clothiapine: highlights on pharmacological and clinical profile of an undervalued drug
C Crapanzano, C Amendola, C Conigliaro, I Casolaro
Swiss Archives of Neurology, Psychiatry and Psychotherapy 173 (03), 2022
32022
Efficacy of olanzapine in anxiety dimension of schizophrenia: a systematic review of randomized controlled trials
C Crapanzano, I Casolaro, S Damiani, C Amendola
Clinical Psychopharmacology and Neuroscience 20 (4), 592, 2022
22022
Combining Aripiprazole and Haloperidol: Focus on D2 Receptor.
C Crapanzano, PF Laurenzi, C Amendola, I Casolaro
Journal of Clinical Pharmacology 62 (7), 2022
22022
Antipsychotic monotherapy in obsessive-compulsive disorder
C Crapanzano, PF Laurenzi, I Casolaro, A Politano, C Amendola
Psychiatria Danubina 34 (1), 106-106, 2022
22022
Brexpiprazole 2 mg Starting Dose: A Case Series
C Crapanzano, I Casolaro, B Beccarini Crescenzi, C Amendola
Psychiatria Danubina 34 (2), 308-309, 2022
12022
Intramuscular and intravenous trazodone for the treatment of agitation
C Crapanzano, M Ballerio, S Bolognesi, A Goracci, A Fagiolini
Eur Neuropsychopharmacol 29, S241, 2019
12019
Clozapine-induced sinus tachycardia in patients treated with a slow titration schedule
G Amodeo, C Crapanzano, I Baldini, N Cipriani, L Del Matto, S Desantis, ...
European Neuropsychopharmacology 26 (Supplement 2), S543-S544, 2016
12016
Prescription Patterns of Intramuscular Medication for Psychomotor Agitation: A Survey of Italian Psychiatrists
C Crapanzano, N Redaelli, A Politano, I Casolaro, C Amendola
Clinical Psychopharmacology and Neuroscience 22 (2), 376, 2024
2024
Case report of lurasidone in the treatment of chronic tic disorders
C Crapanzano, C Amendola, J Steen, I Casolaro
Annals of clinical psychiatry: official journal of the American Academy of …, 2023
2023
P. 290 Early efficacy of trazodone for the treatment of depressive episodes with mixed features in patients with major depressive disorder
VL Serro, C Crapanzano, A Goracci, S Bolognesi, G Di Cicco, E Cini, ...
European Neuropsychopharmacology 29, S212-S213, 2019
2019
P. 641 Anxiety and insomnia as correlates of major depressive disorder with mixed features
A Oneri, C Crapanzano, C Amendola, S Bolognesi, A Goracci, A Fagiolini
European Neuropsychopharmacology 29, S436-S437, 2019
2019
P. 497 Olanzapine in somatic symptoms disorders: a retrospective study
E Cini, A Goracci, S Bolognesi, VL Serro, G Di Cicco, P Carmellini, ...
European Neuropsychopharmacology 29, S348-S349, 2019
2019
Use of parenteral trazodone in bipolar disorder
C Amendola, C Crapanzano, M Ballerio, S Bolognesi, A Goracci, ...
European Neuropsychopharmacology 29, S91-S92, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20